Image

PREVALENCE OF SCAPULAR DYSKINESIS

PREVALENCE OF SCAPULAR DYSKINESIS

Recruiting
27-40 years
All
Phase N/A

Powered by AI

Overview

Objective

This study will aim to determine the prevalence of scapular dyskinesis (SD) among Egyptian physical therapy practitioners and will explore associated epidemiological factors, including age, sex, BMI, shoulder and neck symptoms, and scapular stabilizer muscle strength.

Design

A cross-sectional observational study will be conducted, including 121 licensed Egyptian physical therapists aged 27 to 40 years. Participants will be divided into three age-based groups.

Methods

Each participant will undergo a clinical examination for SD using the Scapular Dyskinesis Test (SDT) and the Lateral Scapular Slide Test (LSST). Pain intensity will be assessed using the Visual Analog Scale (VAS), and musculoskeletal symptoms will be recorded using the Nordic Musculoskeletal Questionnaire (NMQ). Shoulder range of motion and the strength of scapular stabilizer muscles (serratus anterior, middle, and lower trapezius) will also be evaluated. Statistical analysis will include Chi-square tests and one-way ANOVA at a significance level of p < 0.05.

Description

This study will be a cross-sectional observational study designed to investigate the prevalence of scapular dyskinesis (SD) among physical therapy practitioners and to explore associated epidemiological factors. The study will be conducted between October 2024 and January 2025. Ethical approval will be obtained from the Research Ethics Committee of the Faculty of Physical Therapy, Cairo University (P.T.REC/012/005755).

Participants

Sample Size: The sample size will be calculated using SPSS for Windows, version 25, with 80% power at α = 0.05 level using a one-sample t-test. The generated sample size will be 121 physical therapy practitioners.

Selection Criteria:

Inclusion Criteria:

Licensed physical therapy practitioners actively working in clinical settings (Soliño et al., 2024).

Age between 27 and 40 years (Jeong & Kim, 2023).

Minimum of one year of clinical experience or exposure to physical activity (Jeong & Kim, 2023).

No current shoulder pain or symptoms at the time of assessment (Soliño et al., 2024).

Willingness to participate and provide informed consent.

Exclusion Criteria:

Acute shoulder or neck injury within the last month (Jeong & Kim, 2023).

History of upper body orthopedic surgery (Jeong & Kim, 2023).

Known neurological or musculoskeletal disorders affecting shoulder mechanics (Burn et al., 2016).

Participation in overhead or collision sports with high scapular loading (Burn et al., 2016).

Inability to complete assessment procedures due to physical limitations (Soliño et al., 2024).

Subgroups: Participants will be divided into three age-based groups:

Group A: 27-31 years

Group B: Above 31-36 years

Group C: Above 36-40 years

Instrumentation

Body Mass Index (BMI): Weight and height will be measured using calibrated scales, and BMI will be calculated as body mass (kg) / height² (m²). A cutoff of ≥30 kg/m² will be considered obese (Romero et al., 2008).

Scapular Dyskinesis Test (SDT): Will be used to visually assess scapular movement patterns during repeated shoulder flexion and abduction with light weights (Plummer et al., 2017).

Lateral Scapular Slide Test (LSST): Will assess scapular position by measuring the distance from the scapula's inferior angle to the nearest spinous process in different arm positions. A side-to-side difference >1.5 cm will indicate asymmetry (Curtis et al., 2006).

Digital Goniometer: Will be used to assess shoulder range of motion (ROM) with alignment to anatomical landmarks (Correll et al., 2018; Norkin & White, 2016).

Visual Analog Scale (VAS): Will be used to measure pain intensity on a 10 cm line from 0 (no pain) to 10 (worst pain) (Begum et al., 2019).

Nordic Musculoskeletal Questionnaire (NMQ): An Arabic-adapted version will be used to assess musculoskeletal symptoms in specific body regions (Aldhabi et al., 2024).

Manual Muscle Testing (MMT): Strength testing of middle trapezius, lower trapezius, and serratus anterior will be conducted using the Oxford scale (Vijian et al., 2023).

Assessment Procedures

Personal Data: Name, age, sex, weight, and height will be recorded. Informed consent will be obtained from all participants.

BMI Calculation: Weight and height will be measured, and BMI will be computed using the standard formula (Abrantes et al., 2002).

Pain Assessment (VAS): Participants will mark their pain level on a 10 cm visual analog scale.

SDT: Participants will perform repeated shoulder flexion and abduction; abnormal scapular motion will be recorded as "yes" and normal as "no" (Jayasinghe, 2018).

LSST: Bilateral measurements will be taken in different arm positions; >1.5 cm difference will be considered abnormal (Jayasinghe, 2018).

Shoulder ROM Measurement: A digital goniometer will be used; the joint will be positioned and stabilized before measurement (Norkin & White, 2016).

NMQ Administration: A self-administered questionnaire will address demographic, biomechanical, psychological, and environmental factors (Smith et al., 2006).

MMT: Strength of scapular stabilizers will be graded on the Oxford scale; only grade 5 will be included in analysis to avoid confounding.

Glenohumeral Joint Assessment: Passive ROM will be evaluated for pain response and end-feel categorization (Norkin & White, 2016).

Statistical Analysis Data will be expressed as mean ± SD. The Shapiro-Wilk test will be used for normality testing. ANOVA will be applied to compare characteristics among the three subgroups, and the Chi-square test will be used to compare categorical variables. Statistical analysis will be performed using SPSS version 20 (SPSS Inc., Chicago, IL, USA), with significance set at p ≤ 0.05.

Eligibility

Inclusion Criteria:

Licensed physical therapy practitioners actively working in clinical settings (Soliño et al., 2024).

Age between 27 and 40 years (Jeong & Kim, 2023).

Minimum of one year of clinical experience or exposure to physical activity (Jeong & Kim, 2023).

No current shoulder pain or symptoms at the time of assessment (Soliño et al., 2024).

Willingness to participate and provide informed consent.

Exclusion Criteria:

Acute shoulder or neck injury within the last month (Jeong & Kim, 2023).

History of upper body orthopedic surgery (Jeong & Kim, 2023).

Known neurological or musculoskeletal disorders affecting shoulder mechanics (Burn et al., 2016).

Participation in overhead or collision sports with high scapular loading (Burn et al., 2016).

Inability to complete assessment procedures due to physical limitations (Soliño et al., 2024).

Study details
    Shoulder Pain

NCT07123532

Cairo University

9 September 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.